| Adherence to long-term therapies: evidence for action World Health Organization World Health Organization, 2003 | 6693 | 2003 |
| Adherence to long-term therapies: evidence for action E Sabaté World Health Organization, 2003 | 5830 | 2003 |
| Adherence to long-term therapies: evidence for action S De Geest, E Sabaté European Journal of Cardiovascular Nursing 2 (4), 323-323, 2003 | 705 | 2003 |
| Adherence to long-term therapies: evidence for action. PV Burkhart, E Sabaté Journal of Nursing Scholarship 35 (3), 2003 | 537 | 2003 |
| WHO adherence meeting report E Sabate Geneva: World Health Organization, 2001 | 201 | 2001 |
| Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 … D Stark, M Nankivell, E Pujade-Lauraine, G Kristensen, L Elit, M Stockler, ... The lancet oncology 14 (3), 236-243, 2013 | 191 | 2013 |
| The challenge of chronic conditions: WHO responds: the sooner governments act, the better JA Epping-Jordan, R Bengoa, R Kawar, E Sabaté Bmj 323 (7319), 947-948, 2001 | 170 | 2001 |
| Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003 E Sabate apps. who. int/iris/bitstream/handle/10665/42682/9241545992. pdf, 2016 | 146 | 2016 |
| Adherencia a los tratamientos a largo plazo: pruebas para la acción E Sabate Organización Mundial de la Salud (OMS), 2004 | 111 | 2004 |
| Adherence to long-term therapies: policy for action: meeting report, 4-5 June 2001 E Sabaté, World Health Organization World Health Organization, 2001 | 91 | 2001 |
| Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003 E Sabaté WHO/MNC/03.01, 2018 | 66 | 2018 |
| Adherencia a los tratamientos a largo plazo E Sabaté Génova: organización Mundial de la Salud, 2004 | 44 | 2004 |
| NOAC adherence of patients with atrial fibrillation in the real world: dosing frequency matters? J Hwang, S Han, HJ Bae, SW Jun, SW Choi, CH Lee, IC Kim, YK Cho, ... Thrombosis and haemostasis 120 (02), 306-313, 2020 | 42 | 2020 |
| World bank pharmaceuticals R Govindaraj, MR Reich, JC Cohen World Bank, Washington, DC, 2000 | 42 | 2000 |
| Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers E Sabaté, S De Geest Progress in cardiovascular nursing 19 (1), 28-29, 2004 | 27 | 2004 |
| Depression in young people and the elderly E Sabaté Priority medicines for Europe and the world “A public health approach to …, 2004 | 23 | 2004 |
| Adherencia a los tratamientos a largo plazo: pruebas para la acción World Health Organization Organización Mundial de la Salud, 2004 | 23 | 2004 |
| Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers S De Castro, E Sabaté Clinical infectious diseases 37 (Supplement_5), S464-S467, 2003 | 19 | 2003 |
| The magnitude of the problem of poor adherence World Health Organization Adherence to Long-Term Therapies: Evidence for Action, 7-10, 2003 | 13 | 2003 |
| Self-management behaviors of patients with type 1 diabetes: comparing two sources of patient-generated data G Karway, MA Grando, K Grimm, D Groat, C Cook, B Thompson Applied Clinical Informatics 11 (01), 070-078, 2020 | 11 | 2020 |
Michael R. ReichProfessor of International Health Policy, Harvard School of Public Health在 harvard.edu 的电子邮件经过验证
Michael R. ReichProfessor of International Health Policy, Harvard School of Public Health在 harvard.edu 的电子邮件经过验证
Colin MathersConsultant, World Health Organization在 pm.me 的电子邮件经过验证
derek yachVitality Insitute在 thevitalitygroup.com 的电子邮件经过验证